By clicking on "Subscribe" you accept our privacy policy.



Presentation synopsis:

Considerations for key populations

People living with HIV are affected disproportionally by STI and STI infected individuals are more susceptible to HIV infection. This applies especially to men who have sex with men (MSM), transgender persons and sex workers. In this presentation, current issues of concern in the clinical management of STI and HIV are discussed. We need to de-silo STI care and HIV care. Preventive measures in both fields are required to break chains of infection and synergy is needed on the health care provider level. The currently developed NAAT tests promise faster availability of results and will become true point of care tests. This will enable infection management (including counselling, treatment and contact tracing) while the patient waits during a single consultation, further limiting ongoing transmission. Treatment of STI will remain a point of concern in the coming years, either due to emerging antimicrobial resistance or drugs shortages.

Speaker biography:

Dr. Mayer trained in Internal Medicine at Beth Israel Hospital and in Infectious Diseases and Molecular Epidemiology at Brigham and Women’s Hospital. As the founding Medical Research Director of Fenway Health, he created a community health research program that has developed an international reputation for its capability to conduct community-based research. He is currently a Professor of Medicine at Harvard Medical School, a Professor in Global Health and Population at the Harvard TC Chan School of Public Health, and Attending Physician and Director of HIV Prevention Research at Beth Israel Deaconess Hospital.

Starting in 1994, he has been a site Principal Investigator of NIH-funded HTVN, HPTN, MTN, and ATN clinical trials units, focusing on bio-behavioral HIV prevention research, and a member of the scientific leadership of HPTN and HVTN. He has co-authored more than 800 peer-reviewed publications, co-authored the first text on AIDS for the general public and has co-edited 5 academic texts. He has served on the national boards of amfAR, HIVMA, and GLMA, was a member of the CDC/HRSA HIV/AIDS Advisory Committee, and was a member of the Governing Council of the International AIDS Society. He is an Editor-in-Chief of the Journal of the International AIDS Society, and serves on the PEPFAR Scientific Advisory Board.


Registration is open

Second Announcement

Take a look

Call for abstracts

Submissions are closed